1
Hosheng Tu, Barbara Niksch, David Haffner, Gregory Smedley, Olav B Bergheim, Morteza: Ocular implant with therapeutic agents and methods thereof. Glaukos Corporation, Knobbe Martens Olson & Bear, May 4, 2010: US07708711 (70 worldwide citation)

Devices and methods are provided for the treatment of ocular disorders. An ocular implant has a body comprising material that includes a therapeutic drug. The body has an inlet portion and an outlet portion. The inlet portion is configured to reside in an anterior chamber of an eye when the outlet p ...


2
Hosheng Tu, Barbara Niksch, David Haffner, Gregory Smedley, Olav B Bergheim, Morteza Gharib: Ocular implant with therapeutic agents and methods thereof. Dose Medical Corporation, Knobbe Martens Olson & Bear, January 8, 2013: US08348877 (7 worldwide citation)

Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye such that at least a distal end of the implant is temporarily in the anterior chamber. The implant is implanted into eye tissue adjacent the anterior chamber ...


3
Hosheng Tu, Barbara A Niksch, David S Haffner, Gregory T Smedley, Olav B Bergheim, Morteza Gharib, Richard A Hill, Thomas W Burns: Ocular implant with therapeutic agents and methods thereof. Dose Medical Corporation, Knobbe Martens Olson & Bear, June 30, 2015: US09066782 (3 worldwide citation)

Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye. The implant is implanted into eye tissue adjacent the anterior chamber such that a proximal end of the implant resides in the anterior chamber following imp ...


4
Hosheng Tu, Barbara A Niksch, David S Haffner, Gregory T Smedley, Olav B Bergheim, Morteza Gharib, Richard A Hill, Thomas W Burns: Ocular implant with therapeutic agents and methods thereof. DOSE MEDICAL CORPORATION, Knobbe Martens Olson & Bear, October 17, 2017: US09789001

Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye. The implant is implanted into eye tissue adjacent the anterior chamber such that a proximal end of the implant resides in the anterior chamber following imp ...


5
Hosheng Tu, Barbara Niksch, David Haffner, Gregory Smedley, Olav B Bergheim, Morteza: Ocular implant with therapeutic agents and methods thereof. Glaukos Corporation, Knobbe Martens Olson & Bear, September 16, 2010: US20100234790-A1

Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye such that at least a distal end of the implant is temporarily in the anterior chamber. The implant is implanted into eye tissue adjacent the anterior chamber ...


6
OCULAR IMPLANT WITH THERAPEUTIC AGENTS AND METHODS THEREOF. DOSE MEDICAL CORPORATION, January 9, 2014: US20140012177-A1

Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye. The implant is implanted into eye tissue adjacent the anterior chamber such that a proximal end of the implant resides in the anterior chamber following imp ...


7
OCULAR IMPLANT WITH THERAPEUTIC AGENTS AND METHODS THEREOF. June 23, 2016: US20160175151-A1

Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye. The implant is implanted into eye tissue adjacent the anterior chamber such that a proximal end of the implant resides in the anterior chamber following imp ...